157 related articles for article (PubMed ID: 8538200)
21. Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines.
Yoshida S; Honda A; Matsuzaki Y; Fukushima S; Tanaka N; Takagiwa A; Fujimoto Y; Miyazaki H; Salen G
Steroids; 2003 Jan; 68(1):73-83. PubMed ID: 12475725
[TBL] [Abstract][Full Text] [Related]
22. Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomes.
Schwartz AG; Pashko LL
Cancer Lett; 2001 Jul; 168(1):7-14. PubMed ID: 11368871
[TBL] [Abstract][Full Text] [Related]
23. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
Lubet RA; Gordon GB; Prough RA; Lei XD; You M; Wang Y; Grubbs CJ; Steele VE; Kelloff GJ; Thomas CF; Moon RD
Cancer Res; 1998 Mar; 58(5):921-6. PubMed ID: 9500451
[TBL] [Abstract][Full Text] [Related]
24. Genetic susceptibility for C19 androgen induction of ovarian granulosa cell tumorigenesis in SWXJ strains of mice.
Tennent BJ; Shultz KL; Beamer WG
Cancer Res; 1993 Mar; 53(5):1059-63. PubMed ID: 8439952
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one.
Perkins SN; Hursting SD; Haines DC; James SJ; Miller BJ; Phang JM
Carcinogenesis; 1997 May; 18(5):989-94. PubMed ID: 9163685
[TBL] [Abstract][Full Text] [Related]
26. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.
Labrie F; Luu-The V; Labrie C; Bélanger A; Simard J; Lin SX; Pelletier G
Endocr Rev; 2003 Apr; 24(2):152-82. PubMed ID: 12700178
[TBL] [Abstract][Full Text] [Related]
27. Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin.
Sourla A; Richard V; Labrie F; Labrie C
J Endocrinol; 2000 Aug; 166(2):455-62. PubMed ID: 10927635
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
29. Dehydroepiandrosterone (DHEA) and 3 beta-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice.
Pashko LL; Rovito RJ; Williams JR; Sobel EL; Schwartz AG
Carcinogenesis; 1984 Apr; 5(4):463-6. PubMed ID: 6231135
[TBL] [Abstract][Full Text] [Related]
30. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone.
Rao KV; Johnson WD; Bosland MC; Lubet RA; Steele VE; Kelloff GJ; McCormick DL
Cancer Res; 1999 Jul; 59(13):3084-9. PubMed ID: 10397249
[TBL] [Abstract][Full Text] [Related]
31. Dehydroepiandrosterone Research: Past, Current, and Future.
Klinge CM; Clark BJ; Prough RA
Vitam Horm; 2018; 108():1-28. PubMed ID: 30029723
[TBL] [Abstract][Full Text] [Related]
32. Long-term dehydroepiandrosterone and 16alpha-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats.
Simile M; De Miglio M; Calvisi D; Muroni M; Frau M; Asara G; Daino L; Deiana L; Pascale R; Feo F
Carcinogenesis; 2001 Feb; 22(2):301-8. PubMed ID: 11181452
[TBL] [Abstract][Full Text] [Related]
33. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
[TBL] [Abstract][Full Text] [Related]
34. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts.
Couillard S; Labrie C; Bélanger A; Candas B; Pouliot F; Labrie F
J Natl Cancer Inst; 1998 May; 90(10):772-8. PubMed ID: 9605648
[TBL] [Abstract][Full Text] [Related]
35. Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo.
Melvin WS; Boros LG; Muscarella P; Brandes JL; Johnson JA; Fisher WE; Schirmer WJ; Ellison EC
Surgery; 1997 Apr; 121(4):392-7. PubMed ID: 9122868
[TBL] [Abstract][Full Text] [Related]
36. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
Morris KT; Toth-Fejel S; Schmidt J; Fletcher WS; Pommier RF
Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
[TBL] [Abstract][Full Text] [Related]
37. Induction of ovarian granulosa cell tumors in SWXJ-9 mice with dehydroepiandrosterone.
Beamer WG; Shultz KL; Tennent BJ
Cancer Res; 1988 May; 48(10):2788-92. PubMed ID: 2965969
[TBL] [Abstract][Full Text] [Related]
38. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.
Ahmed S; Owen CP; James K; Sampson L; Patel CK
Curr Med Chem; 2002 Jan; 9(2):263-73. PubMed ID: 11860358
[TBL] [Abstract][Full Text] [Related]
39. The Role of Dehydroepiandrosterone (DHEA) in Skeletal Muscle.
Sato K; Iemitsu M
Vitam Horm; 2018; 108():205-221. PubMed ID: 30029727
[TBL] [Abstract][Full Text] [Related]
40. Dehydroepiandrosterone: an inexpensive steroid hormone that decreases the mortality due to sepsis following trauma-induced hemorrhage.
Angele MK; Catania RA; Ayala A; Cioffi WG; Bland KI; Chaudry IH
Arch Surg; 1998 Dec; 133(12):1281-8. PubMed ID: 9865644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
